Protocol for non-clinical testing MCQs With Answer

Introduction: Protocol for non-clinical testing MCQs With Answer

This quiz collection is designed for M.Pharm students to strengthen understanding of protocols used in non-clinical (preclinical) testing. It covers essential elements such as study objectives, design, GLP compliance, selection of species, dose selection, endpoints, sample handling, documentation, quality assurance, and ethical considerations. Each question focuses on practical aspects of preparing, executing, monitoring, and reporting non-clinical studies so students can apply principles in quality control and assurance settings. These MCQs emphasize regulatory expectations, study reproducibility, and critical decision points that ensure data integrity and animal welfare in preclinical safety and pharmacology testing.

Q1. What is the primary purpose of a non-clinical study protocol?

• To document marketing strategy for the test article
• To define objectives, study design, methods, and acceptance criteria so the study is reproducible and interpretable
• To replace informed consent for animals
• To specify the manufacturing process for the test article

Correct Answer: To define objectives, study design, methods, and acceptance criteria so the study is reproducible and interpretable

Q2. Which element must ALWAYS be included in a GLP-compliant non-clinical protocol?

• A commercial development timeline
• Detailed procedures for data recording, chain of custody, and raw data retention
• Marketing cost estimates
• Only high-level aims without methods

Correct Answer: Detailed procedures for data recording, chain of custody, and raw data retention

Q3. In dose selection for toxicity studies, which principle is most appropriate?

• Use the highest feasible dose without considering systemic exposure
• Select doses based on anticipated clinical exposure, margin-of-safety, and MTD/palatability in animals
• Always use a single dose only
• Ignore pharmacokinetics and base doses on body weight alone

Correct Answer: Select doses based on anticipated clinical exposure, margin-of-safety, and MTD/palatability in animals

Q4. Which section of a non-clinical protocol defines the primary and secondary endpoints?

• Appendices
• Objectives and Endpoints section
• Budget section
• Signatures page

Correct Answer: Objectives and Endpoints section

Q5. What is a key responsibility of Quality Assurance (QA) during a GLP study?

• Designing the statistical analysis plan
• Conducting independent audits/inspections to verify compliance with the protocol and SOPs
• Manufacturing the test article
• Performing histopathology assessments

Correct Answer: Conducting independent audits/inspections to verify compliance with the protocol and SOPs

Q6. Why is a study-specific SOP or protocol amendment documented and approved?

• To avoid updating the study record
• To formally record changes, maintain traceability, and ensure all parties agree before implementation
• To allow retrospective changes without notification
• To change objectives without notifying the sponsor

Correct Answer: To formally record changes, maintain traceability, and ensure all parties agree before implementation

Q7. Which factor is critical when selecting animal species for pharmacology and toxicity studies?

• Species availability only
• Phylogenetic similarity, relevant target expression, metabolism, and regulatory expectations
• Preference of the laboratory technician
• Cost alone

Correct Answer: Phylogenetic similarity, relevant target expression, metabolism, and regulatory expectations

Q8. What is the role of sentinel animals in a non-clinical study?

• To be used only as backups after the study
• To monitor early signs of adverse reaction or infection before dosing the full cohort
• To be sacrificed first for histology always
• To carry out pharmacokinetic sampling for humans

Correct Answer: To monitor early signs of adverse reaction or infection before dosing the full cohort

Q9. Which of the following best describes acceptance criteria in a protocol?

• Vague targets that are evaluated at the study end
• Predefined measurable limits used to determine whether study data meet objectives
• Only qualitative statements about success
• Market acceptance thresholds

Correct Answer: Predefined measurable limits used to determine whether study data meet objectives

Q10. What should be included in the test article characterization section of the protocol?

• Only the batch number
• Composition, purity, concentration, formulation, stability, and storage conditions
• Shipping itinerary of the courier
• Clinical administration instructions for humans

Correct Answer: Composition, purity, concentration, formulation, stability, and storage conditions

Q11. Which practice ensures integrity of biological samples collected in a study?

• Labeling samples generically without timestamp
• Using chain-of-custody documentation, correct labeling, appropriate storage, and validated shipping conditions
• Allowing multiple people to relabel samples informally
• Storing all samples at room temperature regardless of requirements

Correct Answer: Using chain-of-custody documentation, correct labeling, appropriate storage, and validated shipping conditions

Q12. How should stopping criteria be handled in a non-clinical protocol?

• Define explicit humane and scientific stopping rules with triggers and decision authority
• Only be decided verbally during the study
• Never be included so the study always continues
• Be left to the animal caretaker without documentation

Correct Answer: Define explicit humane and scientific stopping rules with triggers and decision authority

Q13. What is the importance of describing statistical methods in the protocol?

• Statistics are optional for non-clinical studies
• To ensure appropriate sample size, analysis plan, handling of missing data, and objective interpretation of results
• To allow post-hoc selective analyses only
• To delay analysis until publication

Correct Answer: To ensure appropriate sample size, analysis plan, handling of missing data, and objective interpretation of results

Q14. What documentation must accompany unexpected deviations from the protocol?

• No documentation is required
• Deviation description, root cause, impact assessment, corrective actions, and approval by appropriate personnel
• Only an email note to a colleague
• A verbal explanation at study closeout

Correct Answer: Deviation description, root cause, impact assessment, corrective actions, and approval by appropriate personnel

Q15. In toxicokinetic (TK) studies linked to toxicity studies, what is an essential protocol element?

• Omit sampling time points to reduce cost
• Defined sampling schedule, validated bioanalytical method, and integration with dose levels and timepoints
• Analyze TK only after study report finalization
• Use unvalidated assays to speed timelines

Correct Answer: Defined sampling schedule, validated bioanalytical method, and integration with dose levels and timepoints

Q16. Which ethical approval is typically required before initiating an in vivo non-clinical study?

• No approvals are necessary for animal work
• Institutional Animal Care and Use Committee (IACUC) or equivalent ethical review approval
• Only sponsor verbal consent
• IRB approval intended for human trials

Correct Answer: Institutional Animal Care and Use Committee (IACUC) or equivalent ethical review approval

Q17. What is the correct approach to raw data handling in GLP studies?

• Allow edits without traceability
• Preserve original raw data, provide traceable corrections with reason, and retain per regulatory timelines
• Discard raw notebooks after data entry
• Only keep summaries, not raw data

Correct Answer: Preserve original raw data, provide traceable corrections with reason, and retain per regulatory timelines

Q18. Which item best describes a sponsor’s responsibility in non-clinical testing?

• Performing all laboratory assays personally
• Providing the test article information, study design agreement, funding, oversight, and final acceptance of the study report
• Writing GLP regulations
• Managing animal husbandry directly

Correct Answer: Providing the test article information, study design agreement, funding, oversight, and final acceptance of the study report

Q19. Why is a study report structured and signed-off important after study completion?

• It is optional and rarely used
• It provides a complete, auditable record of methods, results, interpretation, and approvals required for regulatory submissions
• To summarize only positive findings
• To replace raw data storage

Correct Answer: It provides a complete, auditable record of methods, results, interpretation, and approvals required for regulatory submissions

Q20. Which practice reduces bias in non-clinical studies and should be included in the protocol?

• Open-label handling of animals and samples by one unblinded operator only
• Blinding of personnel assessing outcomes, randomized assignment, and predefined assessment criteria
• Choosing endpoints after seeing initial data
• Analyzing only animals with expected results

Correct Answer: Blinding of personnel assessing outcomes, randomized assignment, and predefined assessment criteria

Download